Skip to main content
. 2014 May 21;3:259. doi: 10.1186/2193-1801-3-259

Table 3.

Regression estimated average incremental monthly costs by adverse event count

1st Line Taxane 1st Line Capecitabine 2nd Line Taxane 2nd Line Capecitabine
With any adverse event, $
Chemotherapy costs $478** $630* $513** $118
Other medication costs -$5 $176* -$54* $139*
Hospitalization costs $920** $1,745* $441** $2,771*
Emergency department costs $29 $43* $17 $91*
Outpatient services costs -$280** -$777* $531* $1,319
Total costs $1,142** $1,817* $1,448** $4,437*
With 1–2 adverse events, $
Chemotherapy costs $342* $75 $22 $1
Other medication costs -$3 $151* -$13 $52
Hospitalization costs $169 $755 $57 $1,018
Emergency department costs -$6 $25 $23 $34
Outpatient services costs -$226* -$903* $154 -$19
Total costs $276 $104 $243 $1,087
With 3–4 adverse events, $
Chemotherapy costs $549* $551 $325* -$283
Other medication costs $14 $220* -$101* $260*
Hospitalization costs $296 $1,648 $183 $1,221
Emergency department costs -$12 $50 -$3 $174*
Outpatient services costs -$182 -$817 $1,103** $693
Total costs $667* $1,652 $1,506** $2,065
With greater than 4 adverse events, $
Chemotherapy costs $488* $1,537** $1,053** $535
Other medication costs -$17 $192* -$71* $191*
Hospitalization costs $1,389** $3,393** $934** $5,777**
Emergency department costs $54* $67* $24 $128*
Outpatient services costs -$353** -$555 $593* $3,323*
Total costs $1,562** $4,635** $2,533** $9,954**

Relative to those with no adverse events and adjusted for age (linear) and Charlson Comorbidity Index (categorized 0, 1, 2, and 3+), *p < 0.05, **p < 0.0001.